CLINICAL_TRIALS
withdrawal
· 2012-07-31
Clinical Trial Update: TTP607 in Refractory Solid Malignancies [Phase 1]
Summary
Phase 1 trial of TTP607 for advanced cancers and lymphoma was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers, Lymphoma | Phase 1 | Status: WITHDRAWN